PharmacoEconomics & Outcomes News

, Volume 677, Issue 1, pp 5–5

DBS a cost-effective option for PD in Germany

Clinical study

DOI: 10.1007/s40274-013-0352-3

Cite this article as:
PharmacoEcon Outcomes News (2013) 677: 5. doi:10.1007/s40274-013-0352-3
  • 11 Downloads

Copyright information

© Springer International Publishing Switzerland 2013